Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 2/3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 12Ovarian Neoplasms 11Fallopian Tube Neoplasms 10Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 5Brenner Tumor 5Lung Neoplasms 4Endometrial Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Carcinoma 3Adenocarcinoma of Lung 3Oropharyngeal Neoplasms 2Neurotoxicity Syndromes 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Carcinosarcoma 2Carcinoma, Transitional Cell 2Vomiting 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Recurrent Uterine Corpus Carcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Cancer Resectable 1Pancreatic Adenocarcinoma 1Pancreas Adenocarcinoma 1Pain 1Ovarian Germ Cell Cancer 1

Interventions

pegfilgrastim 1Taxes 1Paclitaxel 1Laparoscopy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Endometrial Adenocarcinoma × Taxes × Clear all
NCT00006011 2015-05-19

Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

GOG Foundation

Phase 3 Completed
659 enrolled 8 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡